Product register expanded to twelve monographs

The register brings together three product families that had previously been maintained as separate work streams. Sterile injectables manufactured under EU/WHO GMP Grade A conditions now sit alongside oral solid-dose presentations and a post-cycle-therapy portfolio, each entry standardised to the same internal template. A monograph in the register is not a marketing sheet: it binds together the finished-product specification, the Certificate of Analysis format, the stability programme and the serialisation layout under a single controlled reference, so that a distributor and a regulator are looking at the same document.

“Every monograph in the register is held to one controlled standard, from finished-product specification through to the serialised pack.”

For distributors, the practical value is consistency at the pack. Every one of the twelve monographs is issued with a GS1 DataMatrix (ECC200) unique identifier carrying the GTIN, expiry, batch and serial in Application Identifiers (01), (17), (10) and (21), with cases and pallets aggregated to SSCC and recorded as EPCIS events. That means each product in the register can be verified and reconciled against the same data model whether it is an ampoule, a tablet or a PCT presentation, which simplifies goods-in checks across a mixed order.

The quality basis for each entry is deliberately uniform. Stability is run to ICH Q1A(R2) with long-term conditions at 25 C/60% RH and accelerated at 40 C/75% RH; sterile products are tested to USP <71> for sterility and <85> for bacterial endotoxins, and oral solids to <711> dissolution and <905> uniformity of dosage units. Every batch is covered by a Batch Manufacturing Record and released by a Qualified Person, with each monograph subject to periodic Product Quality Review under the company's ICH Q10 pharmaceutical quality system.

For patients, the meaning is straightforward. A single register maintained to one documented standard means that a pack reaching a pharmacy shelf, in any of the three families, has been built to the same expectations for identity, tamper-evidence and traceability. The twelve entries are the current published state of the portfolio; the register is a living document, and further monographs will be added as products complete qualification and stability.